Pipeline
Conventional disease-modifying medicines cannot reverse disease…
While conventional disease-modifying medicines can slow pathologic, symptomatic and functional decline, they cannot reverse disease and may suppress repair. By supporting restorative cells and selectively targeting metabolically constrained aggressor cells, our approach not only inhibits auto-inflammation but also enables normal tissue repair. This has the potential to go beyond conventional disease modification by rebuilding damaged tissue to restore normal architecture.
Our pipeline consists of programmed disease-resolving drugs, offering novel treatments for a wide range of disorders. Our lead investigational drug, leramistat, moves the interventional needle from disease modification to disease resolution, helping patients not only reduce symptoms but reverse their decline, regaining lost functionality.
Leramistat is a first-in-class programmed disease-resolving drug.
Proof-of-concept Phase 2 data are already available for the treatment of rheumatoid arthritis. In a severe, difficult to treat population, leramistat was able to control inflammation and stop disease progression.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
